Niche CDMO Position Pepex Biomedical as a development-stage contract development and manufacturing organization (CDMO) specializing in electrochemical biosensors and saliva, blood, and interstitial fluid diagnostics, highlighting potential partnerships for commercial-scale manufacturing and design-for-manufacturability of sensor-based tests.

IP Advantage Leverage Pepex’s extensive IP portfolio with over 30 global patents to reassure potential customers and collaborators of defensible technologies, enabling co-development or licensing deals around proprietary biosensor designs and AJP manufacturing processes.

Rapid AI Insights Emphasize AnalyteAI as a differentiator for near real-time data analysis, offering selling points for test platforms that require quick decision support, remote health monitoring, or integration with existing digital health ecosystems.

Diverse Biomarker Reach Highlight capability to identify hundreds of biomarkers related to cancers, infectious diseases, TBI, and other conditions across multiple sample types, opening opportunities with diagnostics developers, CROs, and hospital systems seeking broad-menu multiplexed sensor solutions.

Early Commercial Potential Target collaborations with major medical device and diagnostics players that have established sales channels and manufacturing scale, aligning Pepex’s niche biosensor platform with their product families to accelerate market entry and reduce development risk.